RB Coughs Up For Digital Diagnostic Development
Reckitt will work with former Sanofi partner ResApp to develop a consumer app which can diagnose common respiratory issues. The partnership represents RB's latest move into the digital space for its Health business.
You may also be interested in...
Australia's ResApp has terminated a deal with RB to bring to market a smartphone app to identify different respiratory conditions. Previously, Sanofi and ResApp failed to agree a deal for the technology.
Reckitt Benckiser is turning to Angela Naef, who has led DuPont Nutrition & BioSciences innovation operation for the past five years, to rejuvenate its global R&D efforts under new CEO Laxman Narasimhan.
Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future.